S122 Effectiveness of Gemcitabine Plus S-1 Combination As First-Line Therapy Tested in Japanese Population for Advanced Biliary Tract Cancer: Systematic Review of Clinical Trials
Ahmed F, Nasr U, Susheela A, Zakaria F, Ali S, Hamdan A, Sajja A, Andrews K, Bobba S, Potla S, Aslam A, Mezidor M, Yukselen Z, Mohan K, Zarrar R, Shahini E, Muniraj T. S122 Effectiveness of Gemcitabine Plus S-1 Combination As First-Line Therapy Tested in Japanese Population for Advanced Biliary Tract Cancer: Systematic Review of Clinical Trials. The American Journal Of Gastroenterology 2021, 116: s51-s51. DOI: 10.14309/01.ajg.0000772960.67902.ee.Peer-Reviewed Original Research